Nidan Laboratories & Healthcare Ltd

Nidan Laboratories & Healthcare Ltd

₹ 27.0 -3.22%
28 Mar - close price
About

Incorporated in 2000, Nidan Laboratories & Healthcare Ltd provides various Healthcare and Diagnostics Services[1]

Key Points

History[1]
Nidan was established in 2000 by Dr. Nitin Thorve and Mrs. Roshan Thorve. The company runs 35 diagnostic centres across greater Mumbai. Nidan operates its centres through the brand named 'Nidan Diagnostics’ and offers services including CT scan, MRI, Ultra Sound, 2D Echo, ECG, etc. The company is listed on NSE.

  • Market Cap 37.6 Cr.
  • Current Price 27.0
  • High / Low 57.7 / 27.0
  • Stock P/E 12.0
  • Book Value 51.3
  • Dividend Yield 0.00 %
  • ROCE 8.17 %
  • ROE 4.94 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Stock is trading at 0.53 times its book value
  • Company's working capital requirements have reduced from 184 days to 137 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -8.43%
  • Company has a low return on equity of 6.78% over last 3 years.
  • Earnings include an other income of Rs.4.52 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2022 Sep 2022 Mar 2023 Sep 2023
13.14 14.09 10.18 11.82
9.52 8.93 8.54 8.48
Operating Profit 3.62 5.16 1.64 3.34
OPM % 27.55% 36.62% 16.11% 28.26%
0.39 0.33 3.00 1.52
Interest 0.95 1.03 1.19 0.98
Depreciation 0.87 1.44 1.66 1.28
Profit before tax 2.19 3.02 1.79 2.60
Tax % 61.19% 23.51% 31.28% 26.15%
0.86 2.32 1.22 1.92
EPS in Rs 0.62 1.67 0.88 1.38
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
20.07 21.41 20.38 29.66 24.27 22.00
12.23 13.78 11.49 20.25 17.47 17.02
Operating Profit 7.84 7.63 8.89 9.41 6.80 4.98
OPM % 39.06% 35.64% 43.62% 31.73% 28.02% 22.64%
0.37 0.01 1.06 0.40 3.33 4.52
Interest 4.75 3.74 3.46 2.66 2.22 2.17
Depreciation 3.24 3.19 3.18 2.63 3.10 2.94
Profit before tax 0.22 0.71 3.31 4.52 4.81 4.39
Tax % 0.00% 0.00% 30.21% 41.15% 26.40%
0.22 0.71 2.30 2.66 3.54 3.14
EPS in Rs 0.22 0.72 2.32 1.91 2.55 2.26
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 4%
TTM: -19%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 68%
TTM: -1%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -18%
Return on Equity
10 Years: %
5 Years: %
3 Years: 7%
Last Year: 5%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 9.90 9.90 9.90 13.90 13.90 13.90
Reserves 0.41 1.13 3.43 52.00 55.54 57.46
32.16 34.35 38.04 19.29 10.93 14.25
0.58 -0.17 2.37 3.29 4.03 3.28
Total Liabilities 43.05 45.21 53.74 88.48 84.40 88.89
23.28 20.10 19.92 20.46 21.39 20.35
CWIP 0.00 0.00 0.23 3.81 0.00 0.00
Investments 0.53 0.53 0.27 0.00 0.00 46.78
19.24 24.58 33.32 64.21 63.01 21.76
Total Assets 43.05 45.21 53.74 88.48 84.40 88.89

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
8.95 4.62 4.35 7.83 13.90
1.00 -0.01 -3.22 -35.74 -2.99
-5.81 -1.56 -1.22 28.72 -10.59
Net Cash Flow 4.14 3.05 -0.10 0.80 0.32

Ratios

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 102.03 92.57 97.25 65.96 90.69
Inventory Days 16.98 12.88 18.17 25.99
Days Payable 116.72 -25.76 213.05 135.84
Cash Conversion Cycle 2.29 131.22 -97.64 -43.89 90.69
Working Capital Days 256.25 291.69 238.56 176.10 136.56
ROCE % 10.13% 13.99% 10.09% 8.17%

Shareholding Pattern

Numbers in percentages

2 Recently
Nov 2021Mar 2022Sep 2022Mar 2023Sep 2023
71.22% 71.22% 71.22% 71.22% 62.79%
28.78% 28.79% 28.78% 28.78% 37.21%
No. of Shareholders 2,9402,7912,5162,4402,777

Documents